AFYA:NSD-Afya Ltd (USD)

COMMON STOCK | Education & Training Services |

Last Closing

USD 16.43

Change

-0.22 (-1.32)%

Market Cap

USD 1.50B

Volume

0.10M

Analyst Target

USD 22.40
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil. Address: Alameda Oscar Niemeyer, No. 119, Nova Lima, MG, Brazil

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-18 )

Largest Industry Peers for Education & Training Services

Symbol Name Price(Change) Market Cap
LOPE Grand Canyon Education Inc

-0.27 (-0.19%)

USD 4.22B
LAUR Laureate Education Inc

-0.04 (-0.24%)

USD 2.52B
STRA Strategic Education Inc

-0.40 (-0.43%)

USD 2.32B
PRDO Perdoceo Education Corp

-0.01 (-0.05%)

USD 1.40B
UDMY Udemy Inc

-0.10 (-1.24%)

USD 1.16B
LINC Lincoln Educational Services

-0.07 (-0.56%)

USD 0.39B
APEI American Public Education Inc

-0.33 (-2.13%)

USD 0.27B
VSTA Vasta Platform Ltd

+0.08 (+3.08%)

USD 0.20B
JZ Jianzhi Education Technology G..

N/A

USD 0.02B
AACG ATA Creativity Global

-0.02 (-2.90%)

USD 0.02B

ETFs Containing AFYA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Education & Training Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -25.08% 45% F 28% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -25.08% 45% F 28% F
Trailing 12 Months  
Capital Gain 2.75% 70% C- 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.75% 70% C- 46% F
Trailing 5 Years  
Capital Gain -30.56% 67% D+ 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.56% 56% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain -0.64% 65% D 42% F
Dividend Return -0.64% 60% D- 38% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 33.29% 70% C- 56% F
Risk Adjusted Return -1.94% 60% D- 38% F
Market Capitalization 1.50B 84% B 76% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.